JoVE Logo

S'identifier

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the reabsorption of these drugs can be hindered. When urine becomes alkaline, weak acidic drugs become predominantly ionized. Due to the decreased permeability of ionized forms through tubular cells, these drugs remain in the lumen and are ultimately expelled in the urine. This mechanism, known as 'ion trapping,' prevents reabsorption and enhances renal clearance of unwanted drugs. For example, in cases of phenobarbital overdose—a weak acid—treatment with bicarbonate is used to alkalinize the urine. This action ionizes the drug, impeding its back diffusion. Similarly, when dealing with an overdose of weakly basic drugs such as amphetamines, urine acidification is employed to ensure the ionized drug is not reabsorbed.

Tags

Renal ExcretionTubular ReabsorptionGlomerular FiltrateDistal Convoluted TubuleLipophilic DrugsPassive ReabsorptionDrug IonizationUrine PHIon TrappingRenal ClearancePhenobarbital OverdoseBicarbonate TreatmentUrine AcidificationWeak AcidsWeak Bases

Du chapitre 3:

article

Now Playing

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

Pharmacokinetics

3.2K Vues

article

3.1 : Pharmacocinétique : Vue d’ensemble

Pharmacokinetics

5.5K Vues

article

3.2 : Mécanisme d’absorption du médicament : transport membranaire passif

Pharmacokinetics

3.6K Vues

article

3.3 : Mécanisme d’absorption du médicament : transport membranaire médié par le transporteur

Pharmacokinetics

3.5K Vues

article

3.4 : Absorption des médicaments : facteurs affectant l’absorption gastro-intestinale

Pharmacokinetics

3.8K Vues

article

3.5 : Biodisponibilité : Vue d’ensemble

Pharmacokinetics

2.7K Vues

article

3.6 : Facteurs influençant la biodisponibilité : élimination au premier passage

Pharmacokinetics

6.1K Vues

article

3.7 : Bioéquivalence : Vue d’ensemble

Pharmacokinetics

921 Vues

article

3.8 : Effet de premier passage

Pharmacokinetics

5.1K Vues

article

3.9 : Évolution temporelle de l’effet du médicament

Pharmacokinetics

1.9K Vues

article

3.10 : Distribution du médicament : liaison tissulaire

Pharmacokinetics

2.5K Vues

article

3.11 : Barrières physiologiques

Pharmacokinetics

3.4K Vues

article

3.12 : Distribution du médicament : liaison aux protéines plasmatiques

Pharmacokinetics

4.8K Vues

article

3.13 : Modèles à compartiments : Modèle à compartiment unique

Pharmacokinetics

2.2K Vues

article

3.14 : Modèles à compartiments : Modèle à deux compartiments

Pharmacokinetics

5.2K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.